George W. Lloyd - 23 Feb 2023 Form 4 Insider Report for Royalty Pharma plc (RPRX)

Role: EVP, Investments & CLO
Signature: /s/ Sean Weisberg, as Attorney-in-Fact for George W. Lloyd
Issuer symbol: RPRX
Transactions as of: 23 Feb 2023
Transactions value $: -$931,658
Form type: 4
Filing time: 27 Feb 2023, 18:14:01 UTC
Previous filing: 22 Nov 2022
Next filing: 30 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RPRX	Class A Ordinary Shares	Sale	-$931,657	-25,000	-7.1%	$37.27	325,000	23 Feb 2023	By GWL 2014 G, LLC	F1
holding	RPRX	Class A Ordinary Shares						495,860	23 Feb 2023	By GWL 2013 NG, LLC
holding	RPRX	Class A Ordinary Shares						273,960	23 Feb 2023	By IRA
holding	RPRX	Class A Ordinary Shares						130,000	23 Feb 2023	By GWL 2020 G, LLC
holding	RPRX	Class A Ordinary Shares						3,000	23 Feb 2023	Direct
holding	RPRX	Class A Ordinary Shares						4,011	23 Feb 2023	By Spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.19 to $37.37 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.19 to $37.37 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.